0002145518-26-000001.txt : 20260715 0002145518-26-000001.hdr.sgml : 20260715 20260715112019 ACCESSION NUMBER: 0002145518-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260715 DATE AS OF CHANGE: 20260715 EFFECTIVENESS DATE: 20260715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SelSym Biotech, Inc. CENTRAL INDEX KEY: 0002145518 ORGANIZATION NAME: EIN: 843857993 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590832 FILM NUMBER: 261176490 BUSINESS ADDRESS: STREET 1: 701 W MAIN ST SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 9195260314 MAIL ADDRESS: STREET 1: 701 W MAIN ST SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0002145518 SelSym Biotech, Inc. 701 W MAIN ST SUITE 200 DURHAM NC NORTH CAROLINA 27701 9195260314 NORTH CAROLINA None None Corporation true Seema Nandi 701 W Main St Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Director Louis Lyon 701 W Main St Suite 200 Durham NC NORTH CAROLINA 27701 Director William Heath 701 W Main St Suite 200 Durham NC NORTH CAROLINA 27701 Director Biotechnology Decline to Disclose 06b false 2026-07-02 false true true false 0 1500000 500000 1000000 false 1 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false SelSym Biotech, Inc. Seema Nandi Seema Nandi CEO 2026-07-14